Home > Publications > Australian Injectable Drugs Handbook

AUSTRALIAN INJECTABLE DRUGS HANDBOOK (AIDH) 

 

AIDH6 | mobile access | AIDH5 updates | AIDH4 updates | Feedback | Volunteer to review | Order Form

The AIDH 6th Edition is now available

The most comprehensive handbook of its kind, AIDH provides up-to-date information on injectable medicines that will be useful in your daily practice.
 
  • The 6th edition contains more than 440 injectable medicines, ALL entries fully revised, including 24 new monographs.
  • Each monograph includes availability, generic/trade names, preparation, administration, stability, compatibility/incompatibility data, special notes. It also contains paediatric-specific information in many monographs.
  • The AIDH has a tough durable cover and enhanced spiral binding. 

 

australian injectable drugs handbook

Accessing the Australian Injectable Drugs Handbook on your smart phone or tablet

Did you know that if your hospital or university has an HCN (Health Communications Network) subscription and you can use the hospital or university’s wi-fi on your device, you can access the Australian Injectable Drugs Handbook? You can access information on more than 400 injectable drugs in the palm of your hand—on the ward, at the patient’s bedside, out visiting a patient, or anywhere! Open your browser and go to aidh.hcn.com.au.

For further enquiries about online subscriptions should be directed to kssales@hcn.com.au.

 


Updates - AIDH 5th Edition

Important updated information or errata that are identified in the AIDH 5th Edition will be noted here.  New monographs are listed here.

  • The calcium gluconate monograph on page 76 has been amended to change some information in the special notes section. The reference to the ampoule containing 10% elemental calcium is incorrect and has been removed. This amendment will be made to the third reprint revised so applies to all copies received before July 2012.
    Amended calcium gluconate monograph
  • The iron polymaltose complex monograph on page 240 has been updated to reflect current practice. This amendment will be made to the third reprint revised so applies to all copies received before August 2012.
    Amended iron polymaltose complex monograph
  • The piperacillin sodium with tazobactam sodium monograph on page 338 has been amended to change some information in the special notes section. The sodium content for Other brands should read 2.35 mmol (54 mg). This amendment will be made to the third reprint revised so applies to copies received before July 2012.
    Amended piperacillin-tazobactam monograph
  • The mycophenolate mofetil monograph on page 293 has been amended to modify the ‘Caution’ in the SPECIAL NOTES. The caution regarding teratogenicity has been changed to recommend precautions for handling but not the need to handle as a cytotoxic. This amendment was made to the first reprint revised and to some copies of the original print run received before September 2011.
    Amended mycophenolate mofetil monograph 

 


New monographs -  AIDH 5th edition

These extra monographs for five new drugs are only available in the online version of AIDH and here. They will be available in print in the 6th edition.

 

 

Updates - AIDH 4th Edition

Important updated information or errata that are identified in the AIDH 4th Edition will be noted here.

  • The magnesium chloride monograph on page 236 has been amended to modify the information on availability. The percentage concentration of magnesium chloride has been removed and the magnesium chloride is described as anhydrous. This amendment was made to the fifth reprint revised so applies to copies received before September 2010.
    Amended magnesium chloride monograph.
  • The sodium bicarbonate monograph on page 333 has been amended to modify the information on compatibility. Calcium chloride has been removed as a compatible drug. This amendment was made to the third reprint revised so applies to copies received before October 2009.
    Amended sodium bicarbonate monograph.
  • The dinoprost monograph on page 123 has been amended to modify the information on availability. This amendment was made to the second reprint revised so only applies to copies received before June 2009.
    Amended dinoprost monograph.
  • The potassium chloride monograph on page 303 has been amended to modify the information for IV infusion. This amendment was made to the second reprint revised so only applies to copies received before June 2009.
    Amended potassium chloride monograph.
  • The potassium dihydrogen phosphate monograph on page 306 has been amended to modify the information for IV infusion. This amendment was made to the second reprint revised so only applies to copies received before June 2009.
    Amended potassium dihydrogen phosphate monograph.
  • The potassium dihydrogen phosphate and dipotassium hydrogen phosphate monograph on page 308 has been amended to modify the information for IV infusion. This amendment was made to the second reprint revised so only applies to copies received before June 2009.
    Amended potassium dihydrogen phosphate and dipotassium hydrogen phosphate monograph.
  • The sodium phosphate and potassium phosphate monograph on page 341 has been amended to modify the information on availability. This amendment was made to the second reprint revised so only applies to copies received before June 2009.
    Amended sodium phosphate and potassium phosphate monograph.
  • CORRECTION: In the tirofiban hydrochloride monograph on page 365 there is a correction to the section for IV infusion. The final concentration should read 0.05 mg/mL (12.5 mg/250 mL). This amendment applies to the first print and the first reprint revised.
    Amended monograph for TIROFIBAN HYDROCHORIDE - April 2009
      
  • CORRECTION: In the cefoxitin monograph on page 77 there is a correction to the table for IV reconstitution. The resultant concentration for the 2 g vial should be 100 mg/mL. This amendment applies to the first print and the first reprint revised.
    Amended monograph for CEFOXITIN SODIUM - February 2009
  • The danaparoid monograph on page 108 has been amended to include information on compatible fluids. This amendment was made to the first reprint revised so only applies to copies received before December 2008.
    Updated monograph for DANAPAROID - December 2008
  • The methylprednisolone sodium succinate on page 246 has been amended to modify the information for IV infusion. This amendment was made to the first reprint revised so only applies to copies received before December 2008. Updated monograph for METHYLPREDNISOLONE SODIUM SUCCINATE - December 2008

 

Updates - AIDH 3rd Edition

Updates for the AIDH 3rd edition are no longer available; this edition is out of date.


Feedback from users

Feedback Survey
Click here to complete our AIDH user survey. The survey takes 5-10 minutes to complete and will provide valuable feedback for future editions of the AIDH.

Due to technological limitations, the survey may only be completed once on an individual computer (IP address).  This survey will be available for completion until 31 August 2012.

Feedback
SHPA welcomes feedback from those who use the AIDH - nurses, pharmacists and others, about improvements in content and/or readability. Send your feedback to publications@shpa.org.au.


Volunteer to review for the next edition of the AIDH

An essential part of the AIDH is that each monograph is read by nurses and pharmacists from different practice settings to ensure that information is conveyed clearly to avoid confusion. Reviewers are acknowledged with thanks in the introductory pages of the AIDH. Participating in a review of the AIDH may contribute to Continuing Professional Development (CPD) points. If you are willing to be involved in future monograph reviews, please email your contact details, level of experience and areas of interest to publications@shpa.org.au.

Member Login

Forgotten your login details?

Join SHPA.
Buy online courses

  • Webinar - Building resilience to manage stress
  • Register for this webinar to hear from Guna Celms and Prof Denis Kiellerup from the Pharmacist Support Service.
  • FREE CPD for community pharmacists: get ready to dispense HIV meds
  • From 1 July 2015, all community pharmacies will be able to dispense HIV antiretroviral medicines. Pharmacists involved in dispensing these medicines must understand these complexities and be equipped to dispense them safely and provide support for their patients who take these medicines.
  • SHPA supports leadership and management skills development
  • Flexible, online, learning package suitable for anyone.

     

    Member Login

    ajax-loader

    Logging Into SHPA Website.